Canaan Partners XI LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed April 5, 2024), Canaan Partners XI LLC reported 3 stock positions worth $90.7 million. Its top holding was Tyra Biosciences (TYRA) at 79.8% of the portfolio, followed by Aeva Technologies (AEVA, 16.0%) and Rallybio (RLYB, 4.2%). Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q2 2026
Location
MENLO PARK, CA
CIK
0001850694
Portfolio Value
$90.7M (Q1 2024)
SEC Filing
0000950123-24-003102 ↗ filed Apr 5, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $90.7M $90.7M Q1 2024 Q2 2024: $82.6M Q2 2024 Q3 2024: $118.1M Q3 2024 Q4 2024: $77.3M Q4 2024 Q1 2025: $66.4M Q1 2025 Q2 2025: $171.8M Q2 2025 Q3 2025: $102.9M Q3 2025 Q4 2025: $136.8M Q4 2025 Q1 2026: $76.1M Q1 2026 Q2 2026: $127.3M Q2 2026

Holdings 3 stocks · $90.7M
TYRA Tyra Biosciences Inc. 79.77% 4,409,991 $72.3M No change
AEVA Aeva Technologies Inc. 16.03% 3,697,039 $14.5M No change
RLYB Rallybio Corp. 4.20% 2,059,712 $3.8M No change

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

Notes & Other Activity Q4 2023 → Q1 2024
DAWN Day One Biopharmaceuticals I COM Sold out 0 $0before exit
ML Moneylion Inc. CL A Sold out 0 $0before exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$127.3MAEVA, TYRA, BLNK
Q1 2026 3$76.1MAEVA, TYRA, BLNK
Q4 2025 4$136.8MTYRA, AEVA, RLYB, BLNK
Q3 2025 3$102.9MAEVA, TYRA, RLYB
Q2 2025 4$171.8MAEVA, TYRA, UPBD, RLYB
Q1 2025 4$66.4MTYRA, AEVA, RLYB, UPBD
Q4 2024 3$77.3MTYRA, AEVA, RLYB
Q3 2024 3$118.1MTYRA, AEVA, RLYB
Q2 2024 3$82.6MTYRA, AEVA, RLYB
Q1 2024 3$90.7MTYRA, AEVA, RLYB